LDL Clinical Trials

• Effectiveness of a Vitamin Mineral Supplement
  ClinicalTrials.gov Identifier: NCT00153764 - Active, not recruiting
  Homocysteine; LDL cholesterol
  
• LDL Receptor Under Ezetimibe and Simvastatin
  ClinicalTrials.gov Identifier: NCT00317993 - Active, not recruiting
  Healthy Men
  
• Safety and Tolerability of Varying Load and Dose of ISIS 301012 in People With Elevated LDL-Cholesterol Levels
  ClinicalTrials.gov Identifier: NCT00216463 - Active, not recruiting
  Hypercholesterolemia
  
• Study in High Risk Patients Switched From Higher Doses of Other Statins to Crestor on the Percentage of Patients Reaching the New LDL-C Target Goal
  ClinicalTrials.gov Identifier: NCT00240344 - Active, not recruiting
  Hypercholesterolemia
  
• H.E.L.P. Apheresis Therapy to Compare the Reduction of LDL Cholesterol
  ClinicalTrials.gov Identifier: NCT00526058 - Recruiting
  Hypercholesterolemia
  
• Effects of Achieving Very Low LDL-Cholesterol After Treatment With Statins on Steroidogenesis and Cognition
  ClinicalTrials.gov Identifier: NCT00522158 - Completed
  Type 2 Diabetes Mellitus; Cardiovascular Disease; LDL Cholesterol; Cognition
  
• Longitudinal LDL-C Studies in Black and White Families
  ClinicalTrials.gov Identifier: NCT00007384 - Active, not recruiting
  Cardiovascular Diseases; Atherosclerosis
  
• A Six-Week Randomized Trial of Lipitor(Atorvastatin) for the Treatment of PCOS Women With Elevated LDL Cholesterol
  ClinicalTrials.gov Identifier: NCT00529542 - Recruiting
  Polycystic Ovary Syndrome
  
• Observational to Investigate the Efficacy of CRESTOR 5mg in Reaching LDL-C Target Goals in Patients Who Are at High Risk for a Cardiovascular Event
  ClinicalTrials.gov Identifier: NCT00347217 - Recruiting
  Hypercholesteremia
  
• Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
  ClinicalTrials.gov Identifier: NCT00536796 - Recruiting
  Hyperlipidemias; Atherosclerosis; Coronary Heart Disease; Carotid Stenosis; Peripheral Vascular Diseases; Diabetes Mellitus
  
• Percentage of Secondary Prevention Patients Treated to Their LDL-C Targets
  ClinicalTrials.gov Identifier: NCT00536965 - Recruiting
  Hyperlipidemias; Atherosclerosis; Coronary Heart Disease; Carotid Stenosis; Peripheral Vascular Diseases; Diabetes Mellitus
  
• DIALOOG: Crestor in Patients With Diabetes Mellitus Type 2: Lowering of LDL-C Levels to New European Guidelines
  ClinicalTrials.gov Identifier: NCT00233649 - Completed
  Diabetes Mellitus Type 2; Crestor, Rosuvastatin; LDL Cholesterol; Observational
  
• Aerobic Exercise Training & the Autonomic System In Patients After Myocardial Infarction or Stroke
  ClinicalTrials.gov Identifier: NCT00259948 - Not yet recruiting
  HR Vaiability, Aerobic Physical Fitness,Blood Pressure, Blood Sugar Level, Blood HDL, LDL
  
• VLDL and LDL Particle Types as Coronary Heart Disease Risk Factors
  ClinicalTrials.gov Identifier: NCT00065793 - Active, not recruiting
  Cardiovascular Diseases; Heart Diseases; Coronary Disease; Myocardial Infarction; Diabetes Mellitus; Diabetes Mellitus, non-insulin dependent
  
• Observational Study to Evaluate LDL-C Lowering Effect of Ezetimibe
  ClinicalTrials.gov Identifier: NCT00457275 - Completed
  Hypercholesterolemia
  
• Effect of Ezetimibe on Platelet Aggregation and LDL Tendency to Peroxidation
  ClinicalTrials.gov Identifier: NCT00466401 - Completed
  Hypercholesterolemia
  
• Direct Statin Comparison of LDL-C Values: an Evaluation of Rosuvastatin Therapy
  ClinicalTrials.gov Identifier: NCT00239330 - Completed
  Hypercholesteremia
  
• Effects of Atorvastatin Versus Probucol on Small Dense LDL
  ClinicalTrials.gov Identifier: NCT00276133 - Completed
  Chronic Nephropathy
  
• Comparison of Efficacy and Safety of Ezetimibe or Statin Monotherapy to Co-Administration of Both
  ClinicalTrials.gov Identifier: NCT00461968 - Completed
  Cholesterol, LDL
  
• ORBITAL: Open-Label Primary Care Study: Rosuvastatin Based Compliance Initiatives Linked To Achievement Of LDL Goals
  ClinicalTrials.gov Identifier: NCT00396240 - Completed
  Primary Hypercholesterolaemia
  
• A Study to Determine the Degree of Additional Reduction in CV Risk in Lowering LDL Below Minimum Target Levels
  ClinicalTrials.gov Identifier: NCT00327691 - Completed
  Cardiovascular Disease; Cerebrovascular Accident; Coronary Heart Disease
  
• The Effect of Serum LDL Lowering on Aspirin Resistance
  ClinicalTrials.gov Identifier: NCT00466154 - Completed
  Aspirin Resistance; Hypercholesterolemia
  
• Paraoxonase and LDL Oxidation in Carotid Artery Disease
  ClinicalTrials.gov Identifier: NCT00011258 - Completed
  Carotid Stenosis
  
• Efavirenz to Nevirapine Switch and LDL-Dyslipidemia
  ClinicalTrials.gov Identifier: NCT00405171 - Terminated
  HIV; Hypercholesterolemia; Antiretroviral Therapy